Reply: MBN 2016 Aesthetic Breast Meeting BIA-ALCL Consensus Conference Report
- PMID: 30489539
- DOI: 10.1097/PRS.0000000000005016
Reply: MBN 2016 Aesthetic Breast Meeting BIA-ALCL Consensus Conference Report
Comment on
-
MBN 2016 Aesthetic Breast Meeting BIA-ALCL Consensus Conference Report.Plast Reconstr Surg. 2018 Jan;141(1):40-48. doi: 10.1097/PRS.0000000000003933. Plast Reconstr Surg. 2018. PMID: 29280860
-
MBN 2016 Aesthetic Breast Meeting BIA-ALCL Consensus Conference Report.Plast Reconstr Surg. 2018 Dec;142(6):968e-969e. doi: 10.1097/PRS.0000000000005015. Plast Reconstr Surg. 2018. PMID: 30239496 No abstract available.
References
-
- Nava MB, Adams WP Jr, Botti G, et al. MBN 2016 Aesthetic Breast Meeting BIA-ALCL Consensus Conference Report. Plast Reconstr Surg. 2018;141:4048.
-
- Clemens MW, Miranda RN. Commentary on: CD30+ T cells in late seroma may not be diagnostic of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37:776778.
-
- Di Napoli A, Pepe G, Giarnieri E, et al. Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma. PLoS One 2017;12:e0181097.
-
- Feldman AL, Harris NL, Stein H, et al. Swerdlow SH, Campo E, Harris NL, et al. Breast implant-associated anaplastic large cell lymphoma: In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition). 2017:Lyon: IARC; 421422.
-
- Clemens MW, Horwitz SM. NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37:285289.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous